FilingFirehose · free AI preview
RIGEL PHARMACEUTICALS INC
RIGL · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 1
Types: Officer Departure
Rigel Pharmaceuticals reported an officer departure on May 20, 2026, per 8-K filing 5.02, with concurrent items filed under section 5.07. This marks one red-flag event in our 90-day monitoring window, with no cyber incidents detected during the same period. The full $49 Report contextualizes this departure within Rigel's 12-month filing history, quantifies dilution risk from equity financings, and surfaces AI-detected risk signals across management and capital structure changes. The full $49 Report adds executive stability analysis, complete financing history, and our proprietary dilution risk score.
Want the full 5-section $49 Report on RIGL?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.